Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ORCHID PHARMA   ACTAVIS
EQUITY SHARE DATA
    ORCHID PHARMA
Mar-23
ACTAVIS
Dec-18
ORCHID PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs43916,126-   
Low Rs27310,818-   
Sales per share (Unadj.) Rs163.13,955.8-  
Earnings per share (Unadj.) Rs13.5-1,274.2-  
Cash flow per share (Unadj.) Rs27.0416.9-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs168.716,315.7-  
Shares outstanding (eoy) m40.82332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.23.4 64.0%   
Avg P/E ratio x26.3-10.6 -248.6%  
P/CF ratio (eoy) x13.232.3 40.8%  
Price / Book Value ratio x2.10.8 255.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m14,5224,480,758 0.3%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m6540-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m6,6591,315,689 0.5%  
Other income Rs m19425,160 0.8%   
Total revenues Rs m6,8531,340,849 0.5%   
Gross profit Rs m1,23534,478 3.6%  
Depreciation Rs m548562,428 0.1%   
Interest Rs m32975,923 0.4%   
Profit before tax Rs m552-578,713 -0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m0-7,334 -0.0%   
Profit after tax Rs m552-423,784 -0.1%  
Gross profit margin %18.52.6 707.8%  
Effective tax rate %01.3 0.0%   
Net profit margin %8.3-32.2 -25.8%  
BALANCE SHEET DATA
Current assets Rs m5,010539,627 0.9%   
Current liabilities Rs m3,719477,372 0.8%   
Net working cap to sales %19.44.7 409.8%  
Current ratio x1.31.1 119.2%  
Inventory Days Days5720 292.9%  
Debtors Days Days1,18066 1,778.9%  
Net fixed assets Rs m7,242148,929 4.9%   
Share capital Rs m4080-   
"Free" reserves Rs m6,4780-   
Net worth Rs m6,8865,426,601 0.1%   
Long term debt Rs m1,4881,910,903 0.1%   
Total assets Rs m12,2528,483,012 0.1%  
Interest coverage x2.7-6.6 -40.5%   
Debt to equity ratio x0.20.4 61.4%  
Sales to assets ratio x0.50.2 350.4%   
Return on assets %7.2-4.1 -175.4%  
Return on equity %8.0-7.8 -102.7%  
Return on capital %10.5-4.8 -217.4%  
Exports to sales %81.90-   
Imports to sales %37.60-   
Net fx Rs m2,7260-   
CASH FLOW
From Operations Rs m183470,046 0.0%  
From Investments Rs m-312258,229 -0.1%  
From Financial Activity Rs m312-806,740 -0.0%  
Net Cashflow Rs m183-78,073 -0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare ORCHID PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ORCHID PHARMA With: GUFIC BIOSCIENCE  ALKEM LABORATORIES  MARKSANS PHARMA.  BETA DRUGS   GODAVARI DRU  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.